Detection of anti-Toxoplasma gondii IgG, IgM and IgA immunoglobulins in the serum, cerebrospinal fluid and saliva of patients with acquired immunodeficiency syndrome and neurotoxoplasmosis;Detecção de imunoglobulinas IgG, IgM e IgA anti-Toxoplasma gondii no soro, líquor e saliva de pacientes com síndrome da imunodeficiência adquirida e neurotoxoplasmose

Arquivos de Neuro-Psiquiatria

Volumn 62, Issue 4, 2004, Pages 1033-1037

  Borges, Aercio Sebastião ^a,c   De Castro Figueiredo, José Fernando ^b  

^a FEDERAL UNIVERSITY OF UBERLÂNDIA   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c NONE   (Brazil)

Author keywords

AIDS; Antibodies; Cerebrospinal fluid; Neurotoxoplasmosis; Saliva; Serum

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; CEREBROSPINAL FLUID; CHILD; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; ENCEPHALITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; NONHUMAN; SALIVA; SENSITIVITY AND SPECIFICITY; TOXOPLASMA GONDII; TOXOPLASMOSIS;

EID: 10944258671     PISSN: 0004282X     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0004-282x2004000600019     Document Type: Article

References (34)

1. Bertoli F, Espino M, Arosemena JR, Fishback JL, Frenkel JK. A spectrum in the pathology of toxoplasmosis in patients with acquired immunodeficiency syndrome. Arch Pathol Lab Med 1995;119:214-224.
2. Dunlop O, Rootwelt V, Sannes M, et al. Risk of toxoplasmic encephalitis in AIDS patients: indications for prophylaxis. Scand J Infect Dis 1996;28:71-73.
3. Frenkel JK, Hassenem KM, Hassenem RS, Brown E, Thulliez P, Quintero-Nunez R. Transmission of Toxoplasma gondii in Panama city, Panama: a five year prospective cohort study of children, cats, rodents, birds and soil. Am J Trop Med Hyg 1995:53:458-468.
4. Garly M, Eskild P, Petersen C, Lundgren JD, Gerstoft J. Toxoplasmosis in Danish AIDS patients. Scand J Infect Dis 1997;29:597-600.
5. Zangerle R, Allergerger F, Pohl P, Fritsch P, Dierich MP. High risk of developing toxoplasmic encephalitis in AIDS patients seropositive to Toxoplasma gondii. Med Microbiol Immunol 1991;180:59-66.
6. Borges AS, Ferreira MS, Nishioka SA, Silvestre MTA, Silva AM, Rocha A. Agreement between premortem and postmortem diagnoses in patients with acquired immunodeficiency syndrome observed at a Brazilian teaching hospital. Rev Inst Med Trop São Paulo 1997;39:217-221.
7. Ferreira MS, Nishioka SA, Silvestre MT, Borges AS, Nunes-Araujo FR, Rocha A. Reactivation of Chagas' disease in patients with AIDS: report of three new cases and review of the literature. Clin Infec Dis 1997;25:1397-1400.
8. Klatt EC, Nichols L, Nogughi TT. Envolving trends revealed by autopsies of patients with the acquired immunodeficiency syndrome. Arch Pathol Lab Med 1994;118:884-890.
9. Tuazon CV. Toxoplasmosis in AIDS patients. J Antimicrob Chemother 1989;23(Suppl):S77-S82.
10. Wanke C, Tuazon CV, Kovacs A, et al. Toxoplasma encephalitis in patients with acquired immune deficiency syndrome: diagnosis and response to therapy. Am J Trop Med Hyg 1987;36:509-516.
11. Luft BJ, Brooks RG, Conley FK, McCabe RE, Reminton JS. Toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome. JAMA 1984;252:913-917.
12. Raffi F, Aboulker J, Michelet C, et al. A prospective study of criteria for the dagnosis of toxoplasmic encephalitis in 186 AIDS patients. AIDS 1997;11:177-184.
13. Darcy F, Foudrinier F, Mougeot G, et al. Diagnostic value of specific IgA antibodies in AIDS patients with Toxoplasma infection: a bicentric evaluation. Immunol Lett 1991;30:345-348.
14. Gross U, Roos T, Appoldt D, Heesemann J. Improved serological diagnosis of Toxoplasma gondii infection by detection of immunoglobulin A (IgA) and IgM antibodies against P30 by using immunoblot technique. J Clin Microbiol 1992;30:1436-1441.
15. Hajeer AH, Balfour AH, Mostratos A, Crosse B. Toxoplasma gondii: detection of antibodies in human saliva and serum. Parasite Immunol 1994;16:43-50.
16. Patel B, Young Y, Duffy K, Tanner RP, Johnson J, Holliman RE. Immunoglobulin-A detection and the investigation of clinical toxoplasmosis. J Med Microbiol 1993;38:286-292.
17. Grant IH, Gold JWM, Rosenblum M, Niedzwiecki D, Armstrong D. Toxoplasma gondii serology in HIV-infected patients: the development of central nervous system toxoplasmosis in AIDS. AIDS 1990;4:519-521.
18. Hellerbrand C, Goebel FD, Disko R. High predictive value of Toxoplasma gondii IgG antibody levels in HIV-infected patients for diagnosis of cerebral toxoplasmosis. Eur J Clin Microbiol Infect Dis 1996;15:869-872.
19. Cimino C, Lipton RB, Williams A, Feraru E, Harris C, Hirschfeld A. The evaluation of patients with human immunodeficiency virus-related disorders and brain mass lesions. Arch Intern Med 1991;151:1381-1384.
20. Luft BJ, Hafner R, Korzun AH, et al. Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. N Engl J Med 1993;329:995-1000.
21. Haverkos HW. Assessment of therapy for toxoplasma encephalitis. Am J Med 1987;82:907-914.
22. Leport C, Raffi F, Matheron S, et al. Treatment of central nervous system toxoplasmosis with pyrimethamine/sulfadiazine combination in 35 patients with the acquired immunodeficiency syndrome. Am J Med 1988;84:94-100.
23. Centers for Disease Control. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR. 1987;36 (Suppl):S1.
24. Voller A, Bartlett A, Bidwell DE. Enzyme immunoassays with especial reference to ELISA techniques. J Clin Pathol 1978;31:507-520.
25. Ammassari A, Scoppettuolo G, Murri R. Changing disease patterns in focal brain lesion-causing disorders in AIDS. J Acquir Immune Defic Syndr Hum Retrovirol 1998;18:365-371.
26. Danneman BR, McCutchan JA, Israelski DM, et al. Treatment of toxoplasmic encephalitis in patients with AIDS: a randomized trial comparing pyrimethamine plus clindamycin to pyrimethamine plus sulfonamides. Ann Intern Med 1992;116:33-43.
27. Holliman RE. Clinical ande diagnostic findings in 20 patients with toxoplasmosis and the acquired immune deficiency syndrome. J Clin Microbiol 1991;35:1-4.
28. Wainstein MV, Wolffenbuttel L, Lopes D K, et al. Sensibilidade e especificidade do diagnóstico clínico, sorológico e tomográfico da encefalite por Toxoplasma gondii na síndrome da imunodeficiência adquirida. Rev Soc Bras Med Trop 1993;26:71-75.
29. Garcia MMA, Amorim MN, Viana LG, Garcia TCM, Katz N, Rabelo ALT. Detection of anti-Schistossoma antibodies in oral fluids. Mem Inst Oswaldo Cruz 1995;90:513.
30. Loyola AM, Durighetto AF Jr, Silva DAO, Mineo JR. Anti-Toxoplasma gondii immunoglobulins A and G in human saliva and serum. J Oral Pathol Med 1997;26:187-191.
31. Silva MV, Camargo ED, Vaz, AJ, Batista L. Immunodiagnosis of human leptospirosis using saliva. Trans R Soc Trop Med Hyg 1992;86:560-561.
32. Bums CA, Ebersole JL, Allansmith MR. Immunoglobulin A antibody levels in human tears, saliva and serum. Infect Immun 1982;36:1019-1022.
33. Grönblad EA. Concentration of immunoglobulins in human whole saliva: effect of physiological stimulation. Acta Odontol Scand 1981;40:87-95.
34. Amato-Neto V, Braz LMA, Jamra LMF, Higaki Y, Pasternak J. Pesquisa do Toxoplasma gondii na saliva de pacientes com síndrome da imunodeficiência adquirida (AIDS). Rev Hosp Clin Fac Med São Paulo 1990;45:171-172.